JAL INNOVATION (SINGAPORE) PTE LTD

General information

Jal innovation (Singapore) PTE Ltd is a renowned member company of the public listed manufacturer, OK Biotech Co. Ltd. With its head office based at Hsinchu, Taiwan, and is FDA, ISO 13485, and GMP certified, Jal innovation is adept to serve its global partners with an integrated and seamless manufacturing facility that offers a plethora of proprietary diabetic monitoring systems and in vitro diagnostic test kits. The Jal Medical Group of Companies, since its inception for more than 20 years, is committed to serving its clients by manufacturing and supplying precision and high quality and superior products at the most competitive pricing.
Jal Innovation aims to provide cost-effective solutions to every continent that are safe, reliable, and make a visible difference in everyday lives. The key business divisions of Jal Innovation include-
• The manufacture of a wide range of Rapid Diagnostic kits specially designed for professional use and home use STD kits for testing.
• A provision of professional and home use blood glucose monitoring systems.
• Professional consultancy services that are provided for the progressive development of rapid diagnostic test kits design as well as the production facilities.
• A collaboration with Nutrisyz Singapore for the global distribution of proprietary medicines and herb-based health supplements. Approval and listing are done with the Singapore Health Science Authority (HSA) for this high efficacy Chinese Proprietary Medical (CPM).
Jal innovation takes the lead in technology and wins tenders from time to time along with winning awards and accolades in a row consecutively. The tenders acclaim to be the largest suppliers of diagnostic test kits in the world. Jail Innovation is also reputed to supply the co-branded WHO pre-qualified HIV 1&2 diagnostic test kits. The high-end manufacturing facilities have enabled Jal innovation to be the largest exporters of In Vitro Diagnostic products in Singapore and also the largest suppliers of new offerings in the field of biomedical facilities across the continents.